Effect of iron-chelating agents on inhibitors of ribonucleotide reductase

Biochem Pharmacol. 1981 May 1;30(9):979-84. doi: 10.1016/0006-2952(81)90043-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Carcinoma, Ehrlich Tumor / enzymology
  • Chelating Agents / pharmacology*
  • Deferoxamine / pharmacology
  • Edetic Acid / pharmacology
  • Female
  • Guanazole / pharmacology
  • Hydroxyurea / pharmacology
  • Iron Chelating Agents*
  • Mice
  • Mice, Inbred ICR
  • Oxyquinoline / pharmacology
  • Ribonucleotide Reductases / antagonists & inhibitors*

Substances

  • Chelating Agents
  • Iron Chelating Agents
  • Oxyquinoline
  • Edetic Acid
  • Ribonucleotide Reductases
  • Guanazole
  • Deferoxamine
  • Hydroxyurea